Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Sep 6, 2024
Date Accepted: May 23, 2025

The final, peer-reviewed published version of this preprint can be found here:

Investigating the Role of Coenzyme A Restriction in the Pathophysiology of Preeclampsia: Protocol for a Combined Patient Screening and Laboratory Study

Al-Jayyousi R, Jan RK, Giddey AD, stanley AG, Parambath A, Mirza FG, Radhakrishnan R, Atiomo W, Hodgman C

Investigating the Role of Coenzyme A Restriction in the Pathophysiology of Preeclampsia: Protocol for a Combined Patient Screening and Laboratory Study

JMIR Res Protoc 2025;14:e66202

DOI: 10.2196/66202

PMID: 41042598

PMCID: 12534760

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Study protocol: Investigating the role of Coenzyme A restriction in the pathophysiology of Pre-eclampsia

  • Reem Al-Jayyousi; 
  • Reem Kais Jan; 
  • Alexander D Giddey; 
  • Adrian G stanley; 
  • Anagha Parambath; 
  • Fadi G Mirza; 
  • Rajan Radhakrishnan; 
  • William Atiomo; 
  • Charlie Hodgman

ABSTRACT

Background:

Pre-eclampsia is one of the three leading causes of maternal mortality worldwide. Un-fortunately, the exact pathogenesis is still unclear. Published metabolomic and gene expression analyses point to Coenzyme A restriction in the placenta as a factor under-pinning the observed complications of pre-eclampsia, but this hypothesis has never been tested.

Objective:

Investigate the role of CoA restriction in pre-eclampsia

Methods:

This manuscript provides a rationale and a protocol for a clinical study and laboratory experiments to test this hypothesis. It involves screening pre-eclamptic patients for elevated levels of key toxic metabolites induced by the restriction. The laboratory study will involve treating cultured trophoblast cells in a variety of ways to determine if Co-enzyme A restriction can be induced. It involves both metabolite profiling of the culture medium for the toxic metabolites and expression profiling of key genes.

Results:

Patients are currently being recruited into the clinical study, and preliminary results will be published in 2026.

Conclusions:

The findings of this study will indicate if Coenzyme A restriction is associated with pre-eclampsia. If so, this provides a significant novel avenue for research into the treatment and prevention of the disease. Clinical Trial: Not applicable


 Citation

Please cite as:

Al-Jayyousi R, Jan RK, Giddey AD, stanley AG, Parambath A, Mirza FG, Radhakrishnan R, Atiomo W, Hodgman C

Investigating the Role of Coenzyme A Restriction in the Pathophysiology of Preeclampsia: Protocol for a Combined Patient Screening and Laboratory Study

JMIR Res Protoc 2025;14:e66202

DOI: 10.2196/66202

PMID: 41042598

PMCID: 12534760

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.